MiniMed Group (MMED) CEO awarded 297,618 RSUs, now holds 916,099 shares

Rhea-AI Filing Summary

MiniMed Group, Inc. reported that Chief Executive Officer Dallara Que received a grant of 297,618 restricted stock units (RSUs) of common stock at no cost, described as a grant, award or other acquisition under the company’s 2026 Long Term Incentive Plan.

The RSUs vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date, tying most of the benefit to future service and performance. Following this award, Que holds 916,099 shares of common stock, including shares expected to be issued upon vesting of one or more RSUs and 1,727 shares acquired through the 2026 Employee Stock Purchase Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dallara Que

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	297,618	$0.00	--

Holdings After Transaction: Common Stock — 916,099 shares (Direct, null)

Footnotes (1)

1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Includes 1,727 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.

Key Figures

RSUs granted: 297,618 shares Grant price per share: $0.00 per share Shares after transaction: 916,099 shares +2 more

5 metrics

RSUs granted 297,618 shares Restricted stock units granted to CEO on July 1, 2026

Grant price per share $0.00 per share RSU grant coded as award with no purchase price

Shares after transaction 916,099 shares Total common stock beneficially owned following RSU grant

ESPP shares 1,727 shares Shares acquired under 2026 Employee Stock Purchase Plan on June 30, 2026

Vesting schedule Three annual installments RSUs vest in equal one-third increments on first three anniversaries

Key Terms

restricted stock units ("RSUs"), Long Term Incentive Plan, Employee Stock Purchase Plan, grant, award, or other acquisition

4 terms

restricted stock units ("RSUs") financial

"Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Long Term Incentive Plan financial

"pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments"

A long term incentive plan is a company program that awards executives and key employees bonuses—often in stock, options, or cash—only if the business meets multi-year performance goals. It links management pay to company results—like tying a coach’s bonus to a team’s multi-season record—so investors monitor it for how leaders are motivated, potential share dilution, and signals about the company’s long-term priorities.

Employee Stock Purchase Plan financial

"Includes 1,727 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

grant, award, or other acquisition financial

"transaction code description shows Grant, award, or other acquisition for this RSU grant"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 05:38 PM Accepted by SEC EDGAR 07/06/2026 - 05:37 PM Learn about SEC filing dates

FAQ

What did MiniMed Group (MMED) CEO Dallara Que report on this Form 4?

Dallara Que reported receiving 297,618 restricted stock units (RSUs) of MiniMed Group common stock as a grant under the 2026 Long Term Incentive Plan. This is equity compensation at no purchase price, not an open-market stock buy or sale.

How do the 297,618 RSUs granted to MiniMed (MMED) CEO vest over time?

The 297,618 RSUs vest in roughly equal one-third portions on the first, second and third anniversaries of the grant date. This schedule means Que earns the full award gradually over three years, encouraging long-term alignment with MiniMed’s performance.

How many MiniMed (MMED) shares does CEO Dallara Que hold after this RSU grant?

After the grant, Dallara Que is reported as beneficially owning 916,099 shares of MiniMed common stock. This figure includes existing shares, shares to be issued as RSUs vest, and 1,727 shares acquired through the 2026 Employee Stock Purchase Plan.

Did the MiniMed (MMED) CEO buy or sell shares on the market in this Form 4?

No open-market buy or sell is reported. The filing shows an acquisition coded as a grant or award of 297,618 RSUs at a price of $0.00 per share, representing equity compensation rather than a market transaction by the CEO.

What MiniMed (MMED) compensation plans are referenced in this CEO Form 4 filing?

The filing references the 2026 MiniMed Group, Inc. Long Term Incentive Plan as the source of the 297,618 RSU grant. It also notes 1,727 shares acquired under MiniMed’s 2026 Employee Stock Purchase Plan, reflecting ongoing employee share accumulation.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dallara Que

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		297,618(1)	A	$0	916,099(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date.

2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

3. Includes 1,727 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)